Jupiter Neurosciences Inc Share Price Today: Live Updates & Key Insights
Jupiter Neurosciences Inc share price today is $0.3758, up -7.88%. The stock opened at $0.4 against the previous close of $0.4, with an intraday high of $0.4 and low of $0.3507.
Jupiter Neurosciences Inc Share Price Chart
Jupiter Neurosciences Inc
Jupiter Neurosciences Inc Share Price Performance
Jupiter Neurosciences Inc Institutional Holdings
Jupiter Neurosciences Inc Market Status
Jupiter Neurosciences Inc Fundamentals
Market Cap 13.77 M
PB Ratio 239.8339
PE Ratio 0.0
Enterprise Value 13.23 M
Total Assets 6.20 M
Volume 258027
Jupiter Neurosciences Inc Company Financials
About Jupiter Neurosciences Inc & investment objective
Company Information Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform products for the treatment of neuroinflammation. The company develops JNS101, which is in Phase II trial for the treatment of Friedreich's Ataxia, a rare inherited disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS108 that is in Phase II trial for treating mild cognitive impairment/early Alzheimer's disease. It is also involved in the development of JNS102, which is in Phase II trial for the treatment of mucopolysaccharidosis type 1; and JNS107 that is in Phase II trial for treating mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome. In addition, the company develops JNS115, which is in Phase IIa trial for the treatment of Parkinson's disease. It has a strategic partnership with Zina Biopharmaceuticals, LLC to advance Phase 2a clinical trial to evaluate the safety, tolerability, and pharmacokinetics of Resveratrol (JOTROLTM) in individuals with Parkinson's disease; and with Aquanova AG to develop a series of consumer-focused nutritional products targeting longevity, aging, and healthspan. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. Jupiter Neurosciences, Inc. was incorporated in 2016 and is headquartered in Jupiter, Florida.
Organisation Biotechnology
Employees 4
Industry Biotechnology
CEO Mr. Christer Rosen
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
